PASITHEA THERAPEUTICS CORP. Interest Expense
PASITHEA THERAPEUTICS CORP. (KTTA) reported Interest Expense of -$117.19 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2023-08-11
- PASITHEA THERAPEUTICS CORP. interest expense for the quarter ending 2023-06-30 was -$117.19K.
- PASITHEA THERAPEUTICS CORP. interest expense for the quarter ending 2023-03-31 was $6.39K.
- PASITHEA THERAPEUTICS CORP. interest expense for fiscal 2022 was $102.00, a 79.92% decline from fiscal 2021.
- PASITHEA THERAPEUTICS CORP. interest expense for fiscal 2021 was $508.00.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 12 month |
|---|---|---|---|
| 2023-06-30 | -$117.19K 10-Q · filed 2023-08-11 | -$110.80K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $6.39K 10-Q · filed 2023-05-12 | ||
| 2022-12-31 | $102.00 10-K · filed 2023-03-30 | ||
| 2021-12-31 | $508.00 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |